ZA919401B - Drug material suitable for micronisation - Google Patents

Drug material suitable for micronisation

Info

Publication number
ZA919401B
ZA919401B ZA919401A ZA919401A ZA919401B ZA 919401 B ZA919401 B ZA 919401B ZA 919401 A ZA919401 A ZA 919401A ZA 919401 A ZA919401 A ZA 919401A ZA 919401 B ZA919401 B ZA 919401B
Authority
ZA
South Africa
Prior art keywords
salt
micronisation
hydroxy
hydroxynaphthoate
material suitable
Prior art date
Application number
ZA919401A
Other languages
English (en)
Inventor
Steven Frederick Beach
Frederick Beach Steven
David William Stuart Latham
William Stuart Latham David
Tony Gordon Roberts
Gordon Roberts Tony
Colin Brian Sidgwick
Brian Sidgwick Colin
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA919401B publication Critical patent/ZA919401B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Saccharide Compounds (AREA)
ZA919401A 1990-11-29 1991-11-28 Drug material suitable for micronisation ZA919401B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909026005A GB9026005D0 (en) 1990-11-29 1990-11-29 Drug material suitable for micronisation

Publications (1)

Publication Number Publication Date
ZA919401B true ZA919401B (en) 1992-07-29

Family

ID=10686212

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919401A ZA919401B (en) 1990-11-29 1991-11-28 Drug material suitable for micronisation

Country Status (27)

Country Link
US (1) US5380922A (xx)
EP (2) EP0639176B1 (xx)
JP (1) JP3375626B2 (xx)
KR (1) KR100192196B1 (xx)
AT (1) ATE144244T1 (xx)
AU (1) AU644505B2 (xx)
BG (1) BG61340B1 (xx)
CA (1) CA2099586C (xx)
CY (1) CY2009A (xx)
CZ (1) CZ282996B6 (xx)
DE (1) DE69122780T2 (xx)
DK (1) DK0639176T3 (xx)
ES (1) ES2093812T3 (xx)
FI (2) FI118155B (xx)
GB (1) GB9026005D0 (xx)
GR (1) GR3022088T3 (xx)
HK (1) HK78997A (xx)
HU (1) HU218205B (xx)
IE (1) IE914146A1 (xx)
OA (2) OA09861A (xx)
PL (2) PL167976B1 (xx)
RU (2) RU2116293C1 (xx)
SG (1) SG49741A1 (xx)
SK (1) SK281095B6 (xx)
TW (1) TW309425B (xx)
WO (1) WO1992009557A1 (xx)
ZA (1) ZA919401B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
AU1229892A (en) * 1992-02-11 1993-09-03 Glaxo Group Limited Benzenedimethanol derivative suitable for micronisation
US6254882B1 (en) 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
JP2002541183A (ja) 1999-04-14 2002-12-03 グラクソ グループ リミテッド 医薬用エアゾール製剤
AU2001292929A1 (en) 2000-09-26 2002-04-08 Temple University Of The Commonwealth System Of Higher Education Analgesic and glucosamine compositions
EP2127641A1 (en) 2008-05-26 2009-12-02 Inke, S.A. Micronisable form of salmeterol xinafoate
KR101100614B1 (ko) 2010-09-20 2011-12-29 한국수력원자력 주식회사 농축폐액 건조물의 펠렛화 장치 및 방법과 이를 이용한 유리조성개발 방법
WO2016142582A1 (en) * 2015-03-11 2016-09-15 Fermion Oy Process for the preparation of crystalline salmeterol and its xinafoate salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation

Also Published As

Publication number Publication date
FI932422A (fi) 1993-05-27
FI932422A0 (fi) 1993-05-27
RU2197475C2 (ru) 2003-01-27
GR3022088T3 (en) 1997-03-31
GB9026005D0 (en) 1991-01-16
HK78997A (en) 1997-06-20
SG49741A1 (en) 1998-06-15
PL169722B1 (pl) 1996-08-30
CA2099586C (en) 2002-06-25
BG61340B1 (en) 1997-06-30
ATE144244T1 (de) 1996-11-15
OA10024A (en) 1996-10-14
TW309425B (xx) 1997-07-01
AU9040291A (en) 1992-06-25
CY2009A (en) 1998-02-20
BG97767A (bg) 1994-12-02
HU218205B (hu) 2000-06-28
US5380922A (en) 1995-01-10
FI118203B (fi) 2007-08-31
WO1992009557A1 (en) 1992-06-11
DK0639176T3 (da) 1996-12-23
SK54593A3 (en) 1993-10-06
FI982081A (fi) 1998-09-28
EP0639176A1 (en) 1995-02-22
EP0639176B1 (en) 1996-10-16
IE914146A1 (en) 1992-06-03
DE69122780T2 (de) 1997-02-20
FI118155B (fi) 2007-07-31
JPH06503082A (ja) 1994-04-07
OA09861A (en) 1994-08-15
CZ101993A3 (en) 1994-01-19
CA2099586A1 (en) 1992-05-30
RU2116293C1 (ru) 1998-07-27
CZ282996B6 (cs) 1997-12-17
HU9301568D0 (en) 1993-09-28
JP3375626B2 (ja) 2003-02-10
PL167976B1 (pl) 1995-12-30
KR100192196B1 (en) 1999-06-15
EP0571669A1 (en) 1993-12-01
AU644505B2 (en) 1993-12-09
ES2093812T3 (es) 1997-01-01
EP0571669B1 (en) 1996-03-06
DE69122780D1 (de) 1996-11-21
FI982081A0 (fi) 1998-09-28
HUT64219A (en) 1993-12-28
SK281095B6 (sk) 2000-11-07

Similar Documents

Publication Publication Date Title
HUT74910A (en) Sustained release compositions and a method of preparing pharmaceutical compositions
GB9026005D0 (en) Drug material suitable for micronisation
ES2077729T3 (es) Procedimiento y dispositivo para la obtencion de particulas esfericas a partir de fase liquida.
MY140392A (en) Powder of amino acids and method for producing the same
AU3595893A (en) Elevated temperature dimensionally stable impact modified polyester with low gas permeability
RU93040704A (ru) 1-гидрокси-2-нафталинкарбоксилатная соль 4-гидрокси-альфа-[[[6-(4-фенилбутокси)гексил]амино]метил]-1,3-бензолдиметанола в форме сферических сращений микрокристаллов, способ ее измельчения, способ ее получения, применение гидроксинафтоата для получения измельченной гидроксинафтоатной соли
JPS6413004A (en) Sustained release ferrous sulfate
MY108410A (en) Drug material suitable for micronisation.
AU5538490A (en) Trajectory solid angle's impacts to physics and high-technologies
GR861872B (en) Pharmaceutical preparation with controlled and slowly active substance release and method for preparing it
Verkhovskii et al. Structure and Properties of Steels After Quenching in Magnetic Liquid
Blokhina et al. Thermal Treatment of High-Dispersed Palladium Powders
Schillings et al. Transparent model systems
Yeo et al. The Microstructures and Mechanical Properties of Extruded Bars of Rapidly Solidified Fe--3. 6 C--Si Alloy Powders
Ermolenko Induced Spin-Orientation Transitions in the Compound TbCo sub 5. 1